GLSI
Price:
$8.8
Market Cap:
$121.82M
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
Industry
Biotechnology
IPO Date
2020-09-25
Stock Exchange
NASDAQ
Ticker
GLSI
According to Greenwich LifeSciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.03. This represents a change of -19.44% compared to the average of -7.48 of the last 4 quarters.
The mean historical PE Ratio of Greenwich LifeSciences, Inc. over the last ten years is -57.14. The current -6.03 PE Ratio has changed 955.29% with respect to the historical average. Over the past ten years (40 quarters), GLSI's PE Ratio was at its highest in in the December 2024 quarter at -4.59. The PE Ratio was at its lowest in in the June 2021 quarter at -193.24.
Average
-57.14
Median
-30.25
Minimum
-248.80
Maximum
-9.26
Discovering the peaks and valleys of Greenwich LifeSciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.35%
Maximum Annual PE Ratio = -9.26
Minimum Annual Increase = -72.31%
Minimum Annual PE Ratio = -248.80
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -9.26 | -39.10% |
| 2023 | -15.20 | -39.40% |
| 2022 | -25.08 | -63.60% |
| 2021 | -68.90 | -72.31% |
| 2020 | -248.80 | 1.35% |
| 2019 | -17.14 | -51.61% |
| 2018 | -35.42 | -5.08% |
The current PE Ratio of Greenwich LifeSciences, Inc. (GLSI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-16.51
5-year avg
-73.45
10-year avg
-57.14
Greenwich LifeSciences, Inc.’s PE Ratio is less than Cognition Therapeutics, Inc. (-3.40), less than Atossa Therapeutics, Inc. (-3.42), less than Tevogen Bio Holdings Inc. (-2.66), less than Oncolytics Biotech Inc. (-3.93), greater than Surrozen, Inc. (-9.33), less than TuHURA Biosciences, Inc. (-1.51), less than Seer, Inc. (-1.36), less than Opus Genetics, Inc. (-2.43), less than Agenus Inc. (-0.69), greater than Immix Biopharma, Inc. (-6.56),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.40 | $129.50M | |
| -3.42 | $98.11M | |
| -2.66 | $83.79M | |
| -3.93 | $98.42M | |
| -9.33 | $156.26M | |
| -1.51 | $100.77M | |
| -1.36 | $107.12M | |
| -2.43 | $153.73M | |
| -0.69 | $137.64M | |
| -6.56 | $162.49M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Greenwich LifeSciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Greenwich LifeSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Greenwich LifeSciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Greenwich LifeSciences, Inc. (GLSI)?
What is the highest PE Ratio for Greenwich LifeSciences, Inc. (GLSI)?
What is the 3-year average PE Ratio for Greenwich LifeSciences, Inc. (GLSI)?
What is the 5-year average PE Ratio for Greenwich LifeSciences, Inc. (GLSI)?
How does the current PE Ratio for Greenwich LifeSciences, Inc. (GLSI) compare to its historical average?